ITL News & Events

MyHealthTest Launches its Fourth Test Service

ITL Health Group (ASX:ITD), is pleased to announce that its wholly owned subsidiary MyHealthTest Pty Ltd (MHT), the direct to consumer pathology test provider, has launched a prostate specific antigen (PSA) test service to help men who wish to monitor their PSA level from home.  The test means MHT is now marketing four test services to total addressable markets in excess of $1bn.

Read More “MyHealthTest Launches its Fourth Test Service” »

1 2 3 4